Delivering Program Compliance Solutions at the HCP 2017 Fall Hospital Pharmacy Conference!
The RxStrategies’ team is prepped and ready to attend the HCP 2017 Fall Hospital Pharmacy Conference October 16-18 in Chicago, Illinois. The country’s most prestigious hospitals and health systems will be gathering at the Reverse Expo sessions, and our team can’t wait to connect with the Hospital Pharmacy Directors that are attending! Connect with…
Connect with us at the 2017 CPCA Annual Conference!
Next week, on October 12-13 in Anaheim, California, the 2017 California Primary Care Association (CPCA) Annual Conference is taking place! Join RxS team members at the Hilton Anaheim for CPCA’s premier event providing opportunities to network with California’s community clinic and health center leaders while gaining insight into cutting-edge health care expertise and educational content. …
Ready to Discuss Today’s Vision, Tomorrow’s Reality
RxStrategies team member Justin Rolling is ready for Oklahoma Primary Care Association’s (OKPCA) 2017 Annual Conference focusing on “Today’s Vision, Tomorrow’s Reality,” a conference about how Federally Qualified Community Health Centers can achieve better health outcomes and a greater quality of care. The conference will be held Wednesday, October 11 and Thursday, October 12 at…
Clinical Insights: October 2, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Verzenio™ (abemaciclib) – September 28, 2017 – The U.S. Food and Drug Administration approved Verzenio™ (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth…
Join Us at the 40th Annual GAPHC Conference!
The 40th Annual Georgia Association for Primary Health Care (GAPHC) Conference is drawing near! October 10-12, we will be gathering in Atlanta, Georgia for the conference to celebrate its 40th year and to discuss topics vital to 340B Program compliance, such as FQHCs, leadership development, TeleHealth, IT/Data Informatics, finances and more. View the tentative schedule…
Working Together for Program Compliance
Attending the Second Annual Council of Pharmacy Executives and Suppliers (CPES) October 4-5 in Franklin, Tennessee? Our team at RxStrategies can’t wait to connect with leading pharmacy executives in the industry as we work together to ensure 340B Program compliance. Network with any of our team members attending the conference: Skip Devanny – Chief…
Ensuring Mission Achievement at the APHCA Annual Conference and Trade Show!
RxStrategies is proud to be a Platinum Level Sponsor of this year’s Alabama Primary Health Care Association (APHCA) 32nd Annual Conference and Trade Show, being held October 3-6 at the Perdido Beach Resort in Orange Beach, Alabama. This year’s focus is “Mission Achievement: All Systems Go,” and will inform and empower key decision makers and…
Clinical Insights: September 22, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Solosec™ (secnidazole) – September 18, 2017 – Symbiomix Therapeutics announced the U.S. Food and Drug Administration (FDA) has approved Solosec™ (secnidazole) 2g oral granules for the…
Connect with us at the Pharmacy Systems Inc. Annual Conference!
RxStrategies is proud to be a Level 3 Sponsor for the PSI Annual Meeting. Our team members Todd Hudnall, National Sales Manager, Midwest Region and Jonathan Ghenn, Vice President of Split Billing/Enterprise Sales, will be attending the Pharmacy Systems Inc. Annual Conference October 2-3 in Dublin, Ohio. They look forward to connecting with pharmacy leaders…
Clinical Insights: September 15, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Aliqopa™ (copanlisib) – September 14, 2017 – The U.S. Food and Drug Administration granted accelerated approval to Aliqopa™ (copanlisib) for the treatment of adults with relapsed…
Temporary Corporate Office Closure Due To Hurricane Irma
RxStrategies’ corporate office is based in South Florida, and as such, the area is recovering from the impact of Hurricane Irma. As local authorities work to clear roadways and restore power to the area, RxStrategies’ corporate office will remain closed on Wednesday, September 13. We will continue to keep you updated regarding when the corporate office will be operational….
Temporary Corporate Office Closure in Advance of Hurricane Irma
RxStrategies corporate office is based in South Florida, and as such we are preparing to deal with the impacts of Hurricane Irma. In recognition of the potential seriousness of Hurricane Irma, and consistent with local and state governmental authorities’ recommendations, the RxStrategies’ corporate office will be closed Thursday and Friday (September 8 & 9). Depending upon the events of the weekend,…